Regenetp (STU:NJT) Short-Term Debt : €0.00 Mil (As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Regenetp Short-Term Debt?

Regenetp's Short-Term Debt for the quarter that ended in Mar. 2023 was €0.00 Mil.

Regenetp's annual Short-Term Debt declined from Dec. 2020 (€1.69 Mil) to Dec. 2021 (€0.00 Mil) but then stayed the same from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil).

Regenetp Short-Term Debt Historical Data

The historical data trend for Regenetp's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenetp Short-Term Debt Chart

Regenetp Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Dec19

Dec20

Dec21

Dec22

Short-Term Debt

Get a 7-Day Free Trial

0.45

0.48

1.69

Regenetp Quarterly Data
	Apr18	Jul18	Oct18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Short-Term Debt	Get a 7-Day Free Trial															0.94	-	-	-	-

Regenetp Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Regenetp Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Regenetp's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenetp (STU:NJT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenetp Inc (STU:NJT) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

RGTPQ:USA

Address

1960 South 4250 West, Salt Lake City, UT, USA, 84104

Website

https://www.polarityte.com

Regenetp Inc Formerly PolarityTE Inc is a clinical-stage biotechnology company developing regenerative tissue products and biomaterials. It's focused on transforming the lives of patients by discovering, designing, and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement, or regeneration of the skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.

Regenetp (STU:NJT) Headlines

No Headlines